George L. King | |
---|---|
Born | 1950 (age 73–74) |
Education | |
Scientific career | |
Fields |
George Liang King [lower-alpha 1] (born 1950) is a Taiwanese-American physician-scientist affiliated with the Joslin Diabetes Center and Harvard Medical School. King is a researcher on how diabetes affects the Asian American population; and on diabetes-related complications. He is the inaugural Thomas J. Beatson, Jr. Chair at Harvard Medical School, [2] as well as Director of Research, Senior Vice President at the Joslin Diabetes Center, where he is also ex officio a board of trustees member. [3]
King was born in 1950. [1] He moved from Taiwan to the United States with his family when he was 10 years old. He learned English from an elementary school teacher in Richmond, Virginia after living in the U.S. and was one of only two Asians in his elementary and high school class. His father suffered from diabetes. [4]
In 1972, King earned a Bachelor of Arts degree from Johns Hopkins University, [5] and later a Doctor of Medicine degree from Duke University School of Medicine. [6] He completed residency at the University of Washington, before pursuing additional training at the National Institutes of Health. [7]
King has been affiliated with Joslin and Harvard since 1981. [8] He was elected to The American Society for Clinical Investigation in 1986. [9] He has published over 350 scientific papers, which have been cited nearly 100 thousand times. [10] These articles mostly correspond to topics in Internal Medicine, Endocrinology and Diabetes Mellitus. His current research aims at finding protective biochemical factors acting to prevent complications in a large, special group of medalist type 1 diabetic patients who have remained relatively healthy even after 50 or more years suffering the disease. [11] [12] King also leads a national effort to improve care for diabetes in Asian Americans, who develop diabetes at low body weight. [13] King is the founder of Joslin's Asian American Diabetes Initiative, [14] which runs Asian Diabetes Clinic, a provider of exceptional patient care, and culture tailored education materials. [13] Since 2011, he Co-chair AANHPI Diabetes Coalition, a large national advocacy group aiming to improve diabetes prevention and management in Asian Americans. [15] In 2018, he was elected a Fellow of the American Association for the Advancement of Science in the biological sciences section. [16]
Harvard Medical School (HMS) is the medical school of Harvard University and is located in the Longwood Medical Area in Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States, and provides patient care, medical education, and research training through its 15 clinical affiliates and research institutes such as Massachusetts General Hospital (MGH), Dana–Farber Cancer Institute, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Mount Auburn Hospital, McLean Hospital, Cambridge Health Alliance, The Baker Center for Children and Families, and Spaulding Rehabilitation Hospital. Harvard Medical School also partners with newer entities such as Harvard Catalyst, Broad Institute of MIT and Harvard, Harvard Stem Cell Institute, the Center for Primary Care, and Wyss Institute for Biologically Inspired Engineering.
Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School and one of the founding members of Beth Israel Lahey Health. It was formed out of the 1996 merger of Beth Israel Hospital and New England Deaconess Hospital. Among independent teaching hospitals, Beth Israel Deaconess Medical Center has ranked in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.
Joslin Diabetes Center is the world's largest diabetes research center, diabetes clinic, and provider of diabetes education. It is located in the Longwood Medical and Academic Area in Boston, Massachusetts, United States. Among the Harvard Medical School affiliated institutions, Joslin is unique in its sole focus on diabetes. Joslin has the world's largest team of board-certified physicians treating diabetes and its complications, as well as the largest staff of Certified Diabetes Educators anywhere in the world. Joslin also supports the world's largest diabetes research team with more than 40 faculty investigators and more than 300 researchers.
The University of Alabama at Birmingham Marnix E. Heersink School of Medicine is the medical school of the University of Alabama at Birmingham (UAB) located in Birmingham, Alabama, United States with branch campuses in Huntsville, Montgomery, and Tuscaloosa. Residency programs are also located in Selma, Huntsville, and Montgomery. It is part of the University of Alabama at Birmingham (UAB) and the UAB Health System, one of the largest academic medical centers in the United States.
Elliott Proctor Joslin was the first medical doctor in the United States to specialize in diabetes and was the founder of the present-day Joslin Diabetes Center in Boston, Massachusetts.
Priscilla White was a pioneer in the treatment of diabetes during pregnancy and type 1 diabetes. She was also a founding member of the Joslin Diabetes Center.
George L. Blackburn was the S. Daniel Abraham Professor of Nutrition and associate director of the division of nutrition at Harvard Medical School. He was also director of the Center for the Study of Nutrition Medicine (CSNM) in the Roberta and Stephen R. Weiner Department of Surgery, and director of the new Feihe Nutrition Laboratory at Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts.
David G. Armstrong is an American podiatric surgeon and researcher most widely known for his work in amputation prevention, the diabetic foot, and wound healing. He and his frequent collaborators, Lawrence A. Lavery and Andrew J.M. Boulton, have together produced many key works in the taxonomy, classification and treatment of the diabetic foot. He is Professor of Surgery with Tenure and director of the Southwestern Academic Limb Salvage Alliance (SALSA) at the Keck School of Medicine of the University of Southern California and has produced more than 700 peer reviewed manuscripts and more than 115 book chapters.
George F. Cahill Jr. was an American scientist who significantly advanced the diabetes mellitus research of the 20th century. He focused on metabolic research, especially concerning human glucose metabolism in diabetic and normal conditions; he also investigated the effect of hunger and fasting on metabolic pathways and ketose processes. He was author and co-author of nearly 200 articles in scientific magazines and books.
Carl Ronald Kahn is an American physician and scientist, best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center, the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.
Karin M. Hehenberger is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology. She has written numerous articles on biotechnology that have been published in peer review journals and worked as an executive for different biotechnology companies and investment firms. She is a faculty member in the department of Molecular Medicine at the Karolinska Institute where she also obtained her M.D. and a Ph.D. in molecular medicine. She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine and industry challenges as well as provided commentary for Fox News, Good Morning America Health, New York One, the USA Today and Forbes.
Sharon A. Anderson is an American physician, educator, and researcher practicing in Portland, Oregon. She has contributed extensively to the study of the progression of chronic kidney disease. Her research has focused on diabetic nephropathy, polycystic kidney disease and the pathophysiology of the aging kidney. She was the first woman to serve as President of the American Society of Nephrology (ASN). She was the Chief of the Department of Medicine at the Veteran's Affairs Medical Center in Portland and is currently the Chair of the Department of Medicine at Oregon Health and Science University (OHSU). She has been appointed to the National Institutes of Health Council of Councils. Her publications as author or co-author number greater than 150.
Sathyanarayana Srikanta is a researcher in the field of endocrinology. Since 1993 he is serving as the medical director at Samatvam Endocrinology Diabetes Center and Jnana Sanjeevini Medical Center in Bangalore, India. He became faculty at the Harvard Medical School and Clinical Investigator of National Institute of Health, USA at the age of 29 years.
Vlado Perkovic is an Australian renal physician and researcher who is the Provost at the University of New South Wales, Sydney, having previously been Dean of Medicine & Health at that University between 2019 and 2023.
Abdul Cader Asmal is a retired physician who was credentialed to practice Medicine in South Africa, the United Kingdom and the United States. He is an activist for Islam condemning both ISIS and Islamophobia alike. In promoting the ‘middle path’ of Islam Asmal has partnered with interfaith coalitions of many traditions. In the medical field, he was recognized for his academic achievements in obtaining the following credentials: an MB BS, MD, PhD, FCP, and FRCP and Board Certification in Internal Medicine, and in Endocrinology and Metabolism. In his pursuit of promoting the image of Islam he was elected as President of the Islamic Center of Boston, the Islamic Council of New England and its Communications’ Director. For his Interfaith work, he was a Director of Inter-Religious Center for Public Life, is on the Board of the Cooperative Metropolitan Ministries and serves on the Needham Clergy Association and the Human Rights’ Committee.
Albert Ernst Renold was a Swiss physician and clinical biochemist noted for his extensive research on diabetes. In 1986 he was awarded the King Faisal International Prize in Medicine for contributions to the understanding of diabetes.
Barbara B. Kahn is an endocrinologist and the George Richards Minot professor of medicine at Harvard Medical School. She is also the vice chair for research strategy in the department of medicine at Beth Israel Deaconess Medical Center, and was formerly the chief of the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess. Her research focuses on insulin resistance and type 2 diabetes.
Jean Elise Schaffer is an American physician-scientist. She is a Senior Investigator at the Joslin Diabetes Center, where she also serves as Associate Research Director, and she is Professor of Medicine at Harvard Medical School. Her work focuses on fundamental mechanisms of metabolic stress responses and the pathophysiology of diabetes complications.
Alexander Marble was an American diabetologist who spent the majority of his career at the Joslin Diabetes Center.
George Stephen Eisenbarth was an American diabetologist who specialized in type 1 diabetes. He helped to establish the autoimmune basis of the disease.